EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease

Yan Li, Xiaoqin Liu, Mi Tian, Ruyi Zou, Yujuan Gao, Mei Huang, Kefeng Zhou, Min Cao, Hourong Cai iD

The Clinical Respiratory Journal · 2023

DOI: 10.1111/crj.13616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2023. Verfasst von Yan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Dermatomyositis, Lung Diseases, Interstitial. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nanjing Municipal Health and Family Planning Commission, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The prognosis of anti‐MDA5 antibody‐positive dermatomyositis/clinically amyopathic dermatomyositis‐associated interstitial lung disease (MDA5‐DM/CADM‐ILD) is poor. This study was to evaluate the effect of serum soluble CD206 (sCD206), a biomarker of macrophage activation, on predicting the interstitial lung disease (ILD) deterioration and prognosis for MDA5‐DM/CADM‐ILD.

Methods

Forty‐one patients diagnosed with MDA5‐DM/CADM‐ILD were retrospectively included. The clinical data were analyzed. Serum sCD206 levels were measured in 41 patients and 30 healthy controls. The relation between sCD206 levels and ILD deterioration was assessed. Receiver operating characteristic (ROC) curve was generated to determine the optimal cut‐off value of sCD206 for predicting outcome. The association between sCD206 and survival was examined.

Results

The median serum sCD206 level in patients was significantly higher than healthy controls (464.1 ng/mL vs. 349.1 ng/mL, P = 0.002). In DM/CADM patients, the sCD206 level was significantly higher in patients with acute/subacute interstitial lung disease (AILD/SILD) than those with chronic interstitial lung disease (CILD) (539.2 ng/mL vs. 309.4 ng/mL, P = 0.005). The AUC of sCD206 was 0.885 for predicting mortality (95% CI 0.779–0.990). Patients were divided into two groups: sCD206 high level group (≥400 ng/mL) and sCD206 low level group (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisLung Diseases, InterstitialHumansRetrospective StudiesPrognosisBiomarkersInterferon-Induced Helicase, IFIH1Disease Progression

Stichwörter der Autor:innen

CD206MDA5clinically amyopathic dermatomyositisdermatomyositisinterstitial lung disease

Substanzen

BiomarkersInterferon-Induced Helicase, IFIH1

Autor:innen und Institutionen

  • Department of Respiratory Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Department of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.

ORCID-Profile: Hourong Cai

Förderung

  • Nanjing Municipal Health and Family Planning Commission
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Li, Y., Liu, X., Tian, M., Zou, R., Gao, Y., Huang, M., Zhou, K., Cao, M., & Cai, H. (2023). Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.13616

Vancouver

Li Y, Liu X, Tian M, Zou R, Gao Y, Huang M, et al. Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease. The Clinical Respiratory Journal. 2023. doi:10.1111/crj.13616

BibTeX
@article{Li2023,
  author = {Li, Yan and Liu, Xiaoqin and Tian, Mi and Zou, Ruyi and Gao, Yujuan and Huang, Mei and Zhou, Kefeng and Cao, Min and Cai, Hourong},
  title = {Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti‐MDA5 antibody‐positive dermatomyositis related interstitial lung disease},
  journal = {The Clinical Respiratory Journal},
  year = {2023},
  doi = {10.1111/crj.13616}
}
Kostenlos starten →